Romosozumab-Aqqg

Brand name: Evenity (2 Syringes)

Rank #399 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$22.3M

Total Cost

Share:

9,087

Total Claims

$22.3M

Total Cost

304

Prescribers

$2,449

Cost per Claim

771

Beneficiaries

9,252

30-Day Fills

$73K

Avg Cost/Provider

30

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$22.3M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $22.3M total

🔎 Data Overview

💰

At $2,449 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $28,870 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Romosozumab-Aqqg

#ProviderSpecialtyLocationClaimsCost
1Edwin YauFamily PracticeMonterey Park, CA380$926K
2Michael DaoInternal MedicineGarden Grove, CA213$526K
3Steven KongPhysician AssistantBrooklyn, NY198$491K
4Tara AdamsNurse PractitionerMacon, GA144$352K
5Jaesoo PakInternal MedicineCerritos, CA130$326K
6Justin RheemInternal MedicineLos Angeles, CA135$325K
7Ricardo Garcia AlemanyRheumatologyHialeah, FL132$316K
8Guillermo ValenzuelaRheumatologyPlantation, FL123$300K
9Homayoun SharimInternal MedicineBeverly Hills, CA107$291K
10Courtney BurlandPhysician AssistantBloomingdale, IL110$272K
11Julia BuchfuhrerRheumatologyDowney, CA117$269K
12Wagdy KadesRheumatologyLos Angeles, CA104$256K
13Ericsson TrieuPhysician AssistantWhittier, CA103$253K
14Duc TranOsteopathic Manipulative MedicineWestminster, CA100$241K
15Annette GantzNurse PractitionerSan Antonio, TX94$230K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
396Fenofibrate Nanocrystallized (Fenofibrate)$23.2M602,181
397Ravulizumab-Cwvz (Ultomiris)$23.1M428
398Roflumilast (Roflumilast)$22.8M97,022
399Romosozumab-Aqqg (Evenity (2 Syringes))$22.3M9,087
400Azithromycin (Azithromycin)$22.2M3,009,458
401Torsemide (Torsemide)$22.2M971,579
402Doxepin Hcl (Doxepin Hcl)$22.2M371,255

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology